Sonia Alonso Lopez
Overview
Explore the profile of Sonia Alonso Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Semmler G, Alonso Lopez S, Pons M, Lens S, Dajti E, Griemsmann M, et al.
Hepatology
. 2025 Jan;
81(2):609-624.
PMID: 39817915
Background And Aims: Around 750,000 patients per year will be cured of HCV infection until 2030. Those with compensated advanced chronic liver disease remain at risk for hepatic decompensation and...
2.
Semmler G, Alonso Lopez S, Pons M, Lens S, Dajti E, Griemsmann M, et al.
J Hepatol
. 2024 Mar;
81(1):76-83.
PMID: 38521170
Background & Aims: Baveno VII has defined a clinically significant (i.e., prognostically meaningful) decrease in liver stiffness measurement (LSM) in cACLD as a decrease of ≥20% associated with a final...
3.
Ibanez-Samaniego L, Baines Garcia A, Alonso Lopez S
Rev Esp Enferm Dig
. 2023 May;
115(11):597-600.
PMID: 37170556
Acute renal failure (ARF) development is likely the most relevant event in the natural history of severely decompensated cirrhosis. It is a common complication affecting 20-49% of inpatients with decompensated...
4.
Shiha G, Soliman R, Mikhail N, Carrat F, Azzi J, Nathalie G, et al.
J Viral Hepat
. 2022 Jun;
29(9):807-816.
PMID: 35657138
We have recently demonstrated the ability of a simple predictive model (GES) score to determine the risk of hepatocellular carcinoma (HCC) after using direct-acting antivirals. However, our results were restricted...
5.
Lazarus J, Villota-Rivas M, Fernandez I, Gea F, Ryan P, Alonso Lopez S, et al.
Commun Med (Lond)
. 2022 May;
2:20.
PMID: 35603271
Background: Direct-acting antivirals can cure ≥95% of hepatitis C virus (HCV) cases, but do not reach everyone in need. This cross-sectional study analyses the HCV cascade of care (CoC) in...
6.
Romero-Gomez M, Aller R, Ampuero J, Fernandez Rodriguez C, Augustin S, Latorre R, et al.
Gastroenterol Hepatol
. 2022 May;
46(3):236-247.
PMID: 35569541
No abstract available.
7.
Semmler G, Meyer E, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, et al.
J Hepatol
. 2021 Dec;
76(4):812-821.
PMID: 34871626
Background & Aims: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality in patients with advanced chronic liver disease (ACLD) caused by chronic hepatitis C who have achieved...
8.
Ahumada A, Rayon L, Uson C, Banares R, Alonso Lopez S
World J Gastroenterol
. 2021 Nov;
27(40):6737-6749.
PMID: 34790004
Hepatitis C virus (HCV) chronic infection is associated with fibrosis progression, end-stage liver complications and HCC. Not surprisingly, HCV infection is a leading cause of liver-related morbidity and mortality worldwide....
9.
Alonso Lopez S, Manzano M, Gea F, Luisa Gutierrez M, Ahumada A, Devesa M, et al.
Hepatology
. 2020 Oct;
72(6):1924-1934.
PMID: 33022803
Background And Aims: Patients with hepatitis C virus (HCV) and advanced fibrosis remain at risk of hepatocellular carcinoma (HCC) after sustained viral response (SVR) and need lifelong surveillance. Because HCC...
10.
Guerra Romero A, Perez Figueras M, Alonso Lopez S
Rev Esp Enferm Dig
. 2019 Nov;
111(12):973.
PMID: 31696725
Hepatitis C virus infection has been associated with many dermatologic conditions such as lichen planus, porphyria cutanea tarda, and cryoglobulinemia. Recently, an association of HCV with systemic sclerosis has been...